Cargando…
Expression profile of CADM1 and CADM4 in triple negative breast cancer with primary systemic therapy
Triple negative breast cancer (TNBC) is defined by a lack of ER, PgR, and HER2 expression, and to date there have been no significant advances in treatment by targeted therapies against those molecules. Therefore, primary systemic therapy (PST) followed by surgery is the standard therapy for patient...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313031/ https://www.ncbi.nlm.nih.gov/pubmed/30655848 http://dx.doi.org/10.3892/ol.2018.9727 |